Community pharmacy advanced adherence services for children and young people with long-term conditions: A cross-sectional survey study.
Adolescent
Caregivers
Child
Community Pharmacy Services
Cross-Sectional Studies
Medication Adherence
Parents
Pharmacies
Pharmacists
Professional Practice
Surveys and Questionnaires
United Kingdom
Journal
Pharmacy practice
ISSN: 1885-642X
Titre abrégé: Pharm Pract (Granada)
Pays: Spain
ID NLM: 101530029
Informations de publication
Date de publication:
Historique:
received:
20
10
2019
accepted:
23
02
2020
entrez:
8
4
2020
pubmed:
8
4
2020
medline:
8
4
2020
Statut:
ppublish
Résumé
The aim of this study was to investigate the provision of community pharmacy services to children and young people with a focus on advanced services such as medicines use review. Perceptions and experiences of community pharmacists, pharmacy staff, young people and their parents or carers on the provision of such services were also explored. Four different cross-sectional, self-administered questionnaires were distributed in parallel to pharmacists, pharmacy staff members, children and young people and parents in the United Kingdom. An outline of pharmacist's current involvement with children and young people was provided by 92 pharmacists. A different group of 38 community pharmacists and 40 non-pharmacist members of pharmacy staff from a total of 46 pharmacies provided information and views on the conduct of Medicines use review with children and young people. Experiences of advanced pharmacy service provision were collected from 51 children and young people and 18 parents. Most pharmacists offered public health advice to children and young people (73/92; 79.3%) and even more (83/92; 90.2%) reported that they often interacted with children and young people with long-term condition. Despite their high levels of interaction, and a majority opinion that medicines use reviews could benefit children (35/38; 92.1%), the number of pharmacies reporting to have conducted medicines use reviews with children was low (5/41). Pharmacists perceived the main barriers to recruitment as consent (17/29; 58.6%), guideline ambiguity (14/29; 48.3%) and training (13/29; 44.8%). A considerable proportion pharmacists (12/29; 41.4%) and other personnel (14/33; 42.4%) working in community pharmacies were unaware that children were potentially eligible for medicines use reviews. Only 29.4% of the 51 children and young people participants had received advice about their long-term condition from a pharmacist and the majority (46/51; 90.2%) had not taken part in an advanced service focused on adherence. While general engagement with children and young people appears high from the pharmacist's perspective, advice specific to children and young people with long-term conditions and the provision of advanced services in this group remains a challenge.
Identifiants
pubmed: 32256895
doi: 10.18549/PharmPract.2020.1.1720
pii: pharmpract-18-1720
pmc: PMC7104799
doi:
Types de publication
Journal Article
Langues
eng
Pagination
1720Informations de copyright
Copyright: © Pharmacy Practice.
Déclaration de conflit d'intérêts
CONFLICT OF INTEREST None declared.
Références
Integr Pharm Res Pract. 2018 Jul 09;7:83-92
pubmed: 30023339
J R Soc Med. 2010 Mar;103(3):98-106
pubmed: 20200181
Arch Dis Child. 2016 Sep;101(9):e2
pubmed: 27540228
Paediatr Drugs. 2007;9(5):283-8
pubmed: 17927300
Int J Pharm Pract. 2018 Apr;26(2):104-110
pubmed: 28370586
Int J Public Health. 2014 Oct;59(5):789-98
pubmed: 25146339
Pharm Pract (Granada). 2019 Jan-Mar;17(1):1355
pubmed: 31015872
J Adolesc Health. 2017 Feb;60(2):219-225
pubmed: 27913114
J Am Pharm Assoc (2003). 2016 May-Jun;56(3):266-269.e1
pubmed: 27156941
Health Expect. 2018 Apr;21(2):409-428
pubmed: 29114971
Patient Prefer Adherence. 2017 Apr 10;11:751-760
pubmed: 28435233
BMC Pediatr. 2014 Mar 04;14:63
pubmed: 24593304
Pharm Pract (Granada). 2008 Oct;6(4):178-86
pubmed: 25157291
J Pediatr Pharmacol Ther. 2017 Nov-Dec;22(6):412-422
pubmed: 29290741
J Clin Nurs. 2016 Nov;25(21-22):3345-3353
pubmed: 27346536
Arch Pediatr Adolesc Med. 2003 Apr;157(4):361-5
pubmed: 12695232
Drug Ther Bull. 2016 Jan;54(1):6-9
pubmed: 26763597
J Am Pharm Assoc (2003). 2017 Jan - Feb;57(1):38-46.e2
pubmed: 27843107